Vor bio to participate in the goldman sachs healthcare conference

Cambridge, mass., june 05, 2023 (globe newswire) -- vor bio (nasdaq: vor), a clinical-stage cell and genome engineering company, will present and host in-person 1x1 investor meetings at the goldman sachs 44th annual global healthcare conference.
VOR Ratings Summary
VOR Quant Ranking